139 related articles for article (PubMed ID: 5566354)
21. [Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy)].
Clavel B
Sem Hop; 1974 Jan; 50(4):287-95. PubMed ID: 4368180
[No Abstract] [Full Text] [Related]
22. Cancer of the kidney: diagnostic, therapeutic, and experimental vistas. The Percy T. Magan Memorial Lecture 1973.
Kaufman JJ
Med Arts Sci; 1973; 27(3):28-38. PubMed ID: 4594800
[No Abstract] [Full Text] [Related]
23. Renal carcinoma with solitary distant metastasis.
Hubmer G; Gnad H; Vilits P
Urol Int; 1984; 39(1):46-8. PubMed ID: 6730117
[TBL] [Abstract][Full Text] [Related]
24. Gallium 67 scanning in patients with renal cell carcinoma.
Antoniades J; Honda T; Croll MN; Brady LW
J Urol; 1973 Apr; 109(4):564-6. PubMed ID: 4695086
[No Abstract] [Full Text] [Related]
25. Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: report of a case.
Krumholz BA; Lobovsky FY; Halitsky V
J Reprod Med; 1973 Feb; 10(2):85-9. PubMed ID: 4697437
[No Abstract] [Full Text] [Related]
26. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
Kjaer M; Frederiksen PL
Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
[No Abstract] [Full Text] [Related]
27. Plasma carcinoembryonic antigen in renal cell carcinoma patients.
Chu TM; Shukla SK; Mittleman AO; Murphy GP
J Urol; 1974 Jun; 111(6):742-4. PubMed ID: 4830874
[No Abstract] [Full Text] [Related]
28. Hormonal therapy in carcinoma of the kidney.
Di Silveiro F; La Pera G; De Matties A; De Vita R
Arch Esp Urol; 1991 Apr; 44(3):319-23. PubMed ID: 1651072
[TBL] [Abstract][Full Text] [Related]
29. The management of metastatic renal cell carcinoma.
Peterson LJ
Compr Ther; 1977 Feb; 3(2):20-4. PubMed ID: 837655
[No Abstract] [Full Text] [Related]
30. Regression of Metastases after Nephrectomy for Renal Cell Carcinoma.
Silber SJ; Chen CY; Gould F
Br J Urol; 1975 Jun; 47(3):259-61. PubMed ID: 1139117
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects.
Bloom HJ
Br J Urol; 1973 Jun; 45(3):237-57. PubMed ID: 4576466
[No Abstract] [Full Text] [Related]
32. Medroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).
Samuels ML; Sullivan P; Howe CD
Cancer; 1968 Sep; 22(3):525-32. PubMed ID: 5673232
[No Abstract] [Full Text] [Related]
33. Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy.
Nakano E; Tada Y; Fujioka H; Matsuda M; Osafune M; Kotake T; Sato B; Takaha M; Sonoda T
J Urol; 1984 Aug; 132(2):240-5. PubMed ID: 6330380
[TBL] [Abstract][Full Text] [Related]
34. Regression of metastatic renal cell carcinoma following nephrectomy.
Garfield DH; Kennedy BJ
Cancer; 1972 Jul; 30(1):190-6. PubMed ID: 5040742
[No Abstract] [Full Text] [Related]
35. [Kidney neoplasms].
Ubelhör R
Wien Klin Wochenschr; 1967 Apr; 79(15):261-2. PubMed ID: 5588952
[No Abstract] [Full Text] [Related]
36. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
37. Adjunctive medroxyprogesterone acetate to radical nephrectomy in category M0 renal cell carcinoma. Preliminary report of a prospective randomized trial.
Pizzocaro G; Di Fronzo G; Piva L; Salvioni R; Ronchi E; Cappelletti V; Giongo A; Mastroberardino E; Cozzoli C; Dormia E; Minervini S; Zanollo A; Fontanella U; Giannoni R; Maggioni A; Lasio E
Eur Urol; 1983; 9(4):202-6. PubMed ID: 6223819
[TBL] [Abstract][Full Text] [Related]
38. Regression of bone metastases from renal cell carcinoma achieved by combined therapy.
Ferreira AM; Mendes JR
Eur Urol; 1976; 2(2):100-1. PubMed ID: 971672
[TBL] [Abstract][Full Text] [Related]
39. Renal adenocarcinoma in children: incidence, therapy and prognosis.
Castellanos RD; Aron BS; Evans AT
J Urol; 1974 Apr; 111(4):534-7. PubMed ID: 4819380
[No Abstract] [Full Text] [Related]
40. Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue.
McDonald MW; Diokno AC; Seski JC; Menon KM
J Surg Oncol; 1983 Mar; 22(3):164-6. PubMed ID: 6834834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
